AMENDMENT TO STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 5th, 2012 • Endo Health Solutions Inc. • Pharmaceutical preparations
THIS AMENDMENT TO STOCK PURCHASE AGREEMENT (“Amendment”) is made and entered into on October 17, 2012, by and among APAX QUARTZ (CAYMAN) L.P. (“Apax”) and ENDO PHARMACEUTICALS INC., ENDO HEALTH SOLUTIONS INC. (formerly known as ENDO PHARMACEUTICALS HOLDINGS INC.), and GENERICS INTERNATIONAL (US PARENT) INC. (collectively, “Endo”). Apax and Endo together are referred to herein as the “Parties.” Capitalized terms used but not defined herein shall have the meanings set forth in the Stock Purchase Agreement.
The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended....Sales and Promotional Services Agreement • November 5th, 2012 • Endo Health Solutions Inc. • Pharmaceutical preparations
This First Amendment (“First Amendment") to the Sales and Promotional Services Agreement dated December 30, 2011 (the “Agreement”), by and between ENDO PHARMACEUTICALS INC., a Delaware corporation ("CLIENT") and VENTIV COMMERCIAL SERVICES, LLC, a New Jersey limited liability company ("VCS"), is entered into as of September 21, 2012 (the “Effective Date”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Agreement.
